Article
ASXL1/2 mutations and myeloid malignancies.
Journal of hematology & oncology - 6 Sept 2022
Medina Edward A, Delma Caroline R, Yang Feng-Chun
Abstract excerpt
Myeloid malignancies develop through the accumulation of genetic and epigenetic alterations that dysregulate hematopoietic stem cell (HSC) self-renewal, stimulate HSC proliferation and result in differentiation defects. The polycomb group (PcG) and trithorax group (TrxG) of epigenetic regulators act antagonistically to regulate the expression of genes key to stem cell functions. The genes encoding these proteins,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
